FATE THERAPEUTICS INCFATEEarnings & Financial Report
Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)
Insys Therapeutics was an American specialty pharmaceutical company based in Chandler, Arizona in 1990. Its main product was Subsys, a sublingual liquid form of the drug fentanyl. Fentanyl is an extremely fast-acting and powerful opioid used to relieve breakthrough pain in cancer patients, and prescription of fentanyl in the US for such pain usually requires documented failure of more conservative therapies.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Redmile Group, LLC | 14.90% | 17.6M | flat | 2024-03-25 |
| The Vanguard Group | 9.43% | 9.3M | — | 2024-02-13 |
| BlackRock, Inc. | 9.20% | 10.5M | flat | 2024-11-08 |
| STATE STREET CORPORATION | 1.89% | 31.2K | ▼ -0.42pp | 2024-01-22 |
| Point72 Asset Management, L.P. | 0.00% | 31.2K | ▼ -4.80pp | 2024-11-14 |
| Boxer Capital, LLC | 0.00% | 31.2K | ▼ -6.30pp | 2024-10-25 |
| OF ABOVE PERSONS | 0.00% | 12.3K | — | 2024-02-09 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-20 | LLC Redmile Group | Director | Other | 8.98M | $0.00 | $0 |
| 2026-04-20 | LLC Redmile Group | Director | Other | 8.98M | $0.00 | $0 |
1–2 of 2